The Utility of Endoscopic Ultrasound–Guided Brachytherapy in Liver Metastasis: A Case Report and Review of the Literature

Nayana E. George¹, Benjamin Tharian¹, Helen Lyo¹, Apoorva Jayarangaiah², Irini Youssef¹, Joie Singh¹, Samy I. McFarlane^1, and Shivakumar Vignesh³

¹Department of Medicine, State University of New York-Downstate Medical Center, Brooklyn, NY 11203

²Department of Internal Medicine, Wake Forest University, Baptist Health Care System, Winston-Salem, North Carolina, U.S.A- 27157

³Division of Gastroenterology, Department of Medicine, State University of New York-Downstate Medical Center, Brooklyn, NY 11203

Cite this paper:
Nayana E. George, Benjamin Tharian, Helen Lyo, Apoorva Jayarangaiah, Irini Youssef, Joie Singh, Samy I. McFarlane and Shivakumar Vignesh. The Utility of Endoscopic Ultrasound–Guided Brachytherapy in Liver Metastasis: A Case Report and Review of the Literature. American Journal of Medical Case Reports. 2018; 6(9):189-192. doi: 10.12691/ajmcr-6-9-5

Abstract

Endoscopic ultrasound guided brachytherapy (EGBT) has been reported to be useful in certain malignancies including esophageal and pancreatic cancers. Percutaneous or surgical placement of radioactive seeds into the liver secondaries (brachytherapy) has been done successfully, however, the utility of EGBT in liver metastasis remains largely unclear. In this case report, we demonstrate the safety, efficacy and feasibility of EUS guided brachytherapy (EGBT) in liver metastasis secondary to leiomyosarcoma.

Keywords:
endoscopic ultrasound guided brachytherapy liver metastasis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Jaques DP, Coit DG, Casper ES, Brennan MF. Hepatic metastases from soft-tissue sarcoma. Ann Surg. 1995 Apr; 221(4): 392-7.
[2]	DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg. 2001 Oct; 234(4): 540-7; discussion 547-8.
[3]	Jin Z, Chang KJ. Endoscopic ultrasound-guided fiducial markers and brachytherapy. Gastrointest Endosc Clin N Am. 2012 Apr; 22(2): 325-31, x.
[4]	Seidensticker M, Wust P, R¨¹hl R, et al. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol Lond Engl. 2010; 5: 24.
[5]	Collettini F, Singh A, Schnapauff D, et al. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol. 2013 Oct; 82(10): e509-14.
[6]	Erickson RA. "Hot stuff": EUS-guided brachytherapy. Gastrointest Endosc. 2005 Nov; 62(5): 808-10.
[7]	Sun S, Xu H, Xin J, Liu J, Guo Q, Li S. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy. 2006 Apr; 38(4): 399-403.
[8]	Lah JJ, Kuo JV, Chang KJ, Nguyen PT. EUS-guided brachytherapy. Gastrointest Endosc. 2005 Nov; 62(5): 805-8.
[9]	Sun S, Qingjie L, Qiyong G, Mengchun W, Bo Q, Hong X. EUS-guided interstitial brachytherapy of the pancreas: a feasibility study. Gastrointest Endosc. 2005 Nov; 62(5): 775-9.
[10]	Guo Y, Liu Y, Li Z, et al. EUS-guided implantation of radioactive iodine-125 seeds in retroperitoneal metastatic adenocarcinoma. Endoscopy. 2009; 41 Suppl 2: E301.